Yahoo Web Search

Search results

1. • 

     Insider Sell: COO Mark Jacobson Sells 24,662 Shares of Axsome Therapeutics Inc (AXSM)

     GuruFocus.com via Yahoo Finance· 2 months ago

     Axsome Therapeutics Inc (NASDAQ:AXSM), a biopharmaceutical company focused on developing novel...

2. • 

     Axsome Therapeutics, Inc. (NASDAQ:AXSM) Is Expected To Breakeven In The Near Future

     Simply Wall St. via Yahoo Finance· 10 months ago

     Axsome Therapeutics, Inc. (NASDAQ:AXSM) is possibly approaching a major achievement in its business,...

3. • 

     Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Earnings Haven't Escaped The Attention Of Investors

     Simply Wall St. via Yahoo Finance· 9 months ago

     Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) price-to-sales (or "P/S") ratio of 19.3x may look like a...

4. • 

     Analysts Are Updating Their Axsome Therapeutics, Inc. (NASDAQ:AXSM) Estimates After Its...

     Simply Wall St. via Yahoo Finance· 2 years ago

     Shareholders of Axsome Therapeutics, Inc. (NASDAQ:AXSM) will be pleased this week, given that the...

5. • 

     Institutional investors in Axsome Therapeutics, Inc. (NASDAQ:AXSM) see US$220m decrease in market...

     Simply Wall St. via Yahoo Finance· 1 year ago

     To get a sense of who is truly in control of Axsome Therapeutics, Inc. (NASDAQ:AXSM), it is...

6. • 

     What Is The Ownership Structure Like For Axsome Therapeutics, Inc. (NASDAQ:AXSM)?

     Simply Wall St. via Yahoo Finance· 2 years ago

     The big shareholder groups in Axsome Therapeutics, Inc. (NASDAQ:AXSM) have power over the company....

7. • 

     Axsome Therapeutics Stock: Bear vs. Bull

     Motley Fool· 1 year ago

     Axsome Therapeutics (NASDAQ: AXSM) was one of last year's hottest stocks. The biotech company had reached an exciting time: the launch of its first...

8. • 

     Missed Out On Axsome Therapeutics? My Best Biotech Stock to Buy and Hold

     Motley Fool· 2 years ago

     Axsome Therapeutics wowed investors when it soared more than 80% this year through August. Investors...

9. • 

     Why Axsome Therapeutics Stock Is Crushing It Today

     Motley Fool· 2 years ago

     The stock price of the specialist in central nervous system disorders is shooting higher today in response to the Food and Drug Administration's (FDA)...

10. • 

      Axsome Therapeutics Stock Clears Key Benchmark, Hits 80-Plus RS Rating

      Investor's Business Daily· 8 months ago

      Decades of market research shows that the stocks that go on to make the biggest gains typically have...